JPGN reports · 3 authors, 4 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This case series of 7 teenagers with severe, recurrent iron-deficiency anemia (IDA) linked to H. pylori infection found that all patients achieved and maintained normal iron levels for a median of 20 months after successful H. pylori eradication therapy, even after iron supplementation was stopped.
This study is a case series of 7 H. pylori-infected teenagers aged 12–16 years with recurrent or refractory iron-deficiency anemia (IDA). After successful H. pylori eradication and a short course of iron supplementation, patients were followed for a median of 20 months. Central results showed that compared to baseline, hemoglobin, serum iron, and ferritin levels significantly increased 2–3 months post-eradication and were maintained at normal levels at final follow-up, with no recurrence of IDA. The authors note that H. pylori infection, likely synergizing with increased iron demands from adolescent growth and sports activities, is a key factor in the pathogenesis of IDA.
